.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Find suppliers and generic API sources

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
McKinsey
Novartis
Julphar
Express Scripts
Chinese Patent Office
Mallinckrodt
Colorcon
Moodys

Generated: July 24, 2017

DrugPatentWatch Database Preview

Diethylcarbamazine citrate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diethylcarbamazine citrate and what is the scope of diethylcarbamazine citrate freedom to operate?

Diethylcarbamazine citrate
is the generic ingredient in one branded drug marketed by Lederle and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for diethylcarbamazine citrate.

Summary for Generic Name: diethylcarbamazine citrate

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list5
Bulk Api Vendors: see list38
Clinical Trials: see list528
Patent Applications: see list408
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diethylcarbamazine citrate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle
HETRAZAN
diethylcarbamazine citrate
TABLET;ORAL006459-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
UBS
Deloitte
Fuji
Johnson and Johnson
Novartis
AstraZeneca
Healthtrust
Daiichi Sankyo
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot